These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5667022)

  • 1. Beta adrenergic antagonists, including ICI 50172, and the control of cardiac arrhythmias.
    Nayler WG; Chan J; Lowe TE
    Med J Aust; 1968 Jun; 1(26):1128-30. PubMed ID: 5667022
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental cardiac arrhythmias in the evaluation of anti-arrhythmic drugs.
    Allen JD; Ekue JM; Pantridge JF; Shanks RG; Zaidi SA
    Br J Anaesth; 1971 Jul; 43(7):720-1. PubMed ID: 4398093
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT
    J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of lidocaine, propranolol, and sotalol on ouabain-induced changes in transmembrane potential of canine Purkinje fibers.
    Koerpel BJ; Davis LD
    Circ Res; 1972 Jun; 30(6):681-9. PubMed ID: 5025676
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiarrhythmic effects of dichloroisoprenaline, H 56-28, ICI 50172, LB 46, MJ 1999 and propranolol on aconitine-induced atrial and ouabain-induced ventricular arrhythmias.
    Hashimoto K; Nakayama K; Oshima T; Kumakura S
    Experientia; 1971 Jun; 27(6):666-7. PubMed ID: 4397569
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental study of the anti-arrhythmic activity of some beta-blocking drugs].
    Arcangeli A; Sarcinelli L; Brusadelli S
    Acta Anaesthesiol; 1968; ():Suppl 8:335+. PubMed ID: 4393552
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental cardiac arrhythmias in the evaluation of anti-arrhythmic drugs.
    Allen EKUE JM; Pantridge JF; Shanks RG; Zaidi SA
    Br J Anaesth; 1971 Jul; 43(7):720-1. PubMed ID: 5564246
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the anti-arrhythmic action and beta-blocking potency of LB 46 and (--)-propranolol.
    Flórez J; Arconada JA
    Arch Int Pharmacodyn Ther; 1971 Mar; 190(1):199-207. PubMed ID: 4396347
    [No Abstract]   [Full Text] [Related]  

  • 9. The development of new antidysrhythmic drugs.
    Williams EM
    Schweiz Med Wochenschr; 1973 Feb; 103(8):262-71. PubMed ID: 4144416
    [No Abstract]   [Full Text] [Related]  

  • 10. Modification of ventricular fibrillation thresholds after sympatholytic drugs in the dog.
    Wellens D; Wauters E
    Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):355-71. PubMed ID: 4403391
    [No Abstract]   [Full Text] [Related]  

  • 11. Action of beta-adrenolytics on the isolated guinea-pig atria.
    Grodzińska L; Gryglewski R
    Arch Int Pharmacodyn Ther; 1971 May; 191(1):133-41. PubMed ID: 4397624
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiarrhythmic agents. I. Mechanisms of action and clinical pharmacology.
    Mason DT; DeMaria AN; Amsterdam EA; Zelis R; Massumi RA
    Drugs; 1973; 5(4):261-91. PubMed ID: 4146767
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
    Ferrini R; Miragoli G; Croce G
    Arzneimittelforschung; 1970 Aug; 20(8):1074-9. PubMed ID: 4394830
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiarrhythmic drugs: electrophysiological actions.
    Bassett AL; Hoffman BF
    Annu Rev Pharmacol; 1971; 11():143-70. PubMed ID: 4402439
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of different drugs with beta-adrenolytic activity on experimental models of arrhythmias.
    Marmo E
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 269(2):231-47. PubMed ID: 4397723
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cardiovascular agents. 9. Effects of 1-tert-butylamino-3-(O-tetrahydrofurfuryloxy) phenoxy)-2-propanol hydrochloride (Y-6124) on experimental arrhythmia in dogs].
    Nakanishi M; Imamura H; Nakamura T
    Nihon Yakurigaku Zasshi; 1972 Mar; 68(2):240-53. PubMed ID: 4403394
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of beta-adrenoreceptor blocking agents on the deslanoside-induced arrhythmia and cardiac arrest in guinea pigs.
    Otorii T
    Jpn Circ J; 1971 Dec; 35(12):1535-40. PubMed ID: 4401761
    [No Abstract]   [Full Text] [Related]  

  • 18. [The beta-adrenergic blockers as anti-arrhythmics].
    Nadal-Ginard B; Sanz G; Cárdenas M
    Arch Inst Cardiol Mex; 1970; 40(4):461-70. PubMed ID: 4394936
    [No Abstract]   [Full Text] [Related]  

  • 19. General concepts in the use of beta-blockers: the relative roles of specific and unspecific effects.
    Brunner H; Hedwall PR; Meier M
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 269(2):219-31. PubMed ID: 4397722
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-arrhythmic effects of a beta-adrenolytic agent dl (hydroxy 2't-butylamino-3' propyloxy) 8-thiochromane (S 2395)].
    Laubie M; Cheymol G; Mouillé P; Gilbert JC; Schmitt H
    Arch Int Pharmacodyn Ther; 1973 Feb; 201(2):323-33. PubMed ID: 4146788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.